{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:17:05Z","timestamp":1790914625891,"version":"4.1.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82192915"],"award-info":[{"award-number":["82192915"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013071","name":"Major Program of National Fund of Philosophy and Social Science of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82300964"],"award-info":[{"award-number":["82300964"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phrs.2025.107972","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:09:37Z","timestamp":1758773377000},"page":"107972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The role of hypothalamus in the pathophysiological process of MASLD and advances in drug discovery"],"prefix":"10.1016","volume":"221","author":[{"given":"Shizhang","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"And N.N.c. group, a multisociety delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.07.031","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD","volume":"80","author":"De","year":"2024","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2025.107972_bib4","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","article-title":"Prevalence of liver steatosis and fibrosis in the general population and various High-Risk populations: a nationwide study with 5.7 million adults in China","volume":"165","author":"Man","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2025.107972_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154342","article-title":"Revealing the role of peroxisome proliferator-activated receptor beta\/delta in nonalcoholic fatty liver disease","volume":"114","author":"Zarei","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2025.107972_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154708","article-title":"Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?","volume":"117","author":"Longo","year":"2021","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmet.2024.03.016","article-title":"Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulation","volume":"36","author":"Leeson-Payne","year":"2024","journal-title":"Cell Metab."},{"issue":"8035","key":"10.1016\/j.phrs.2025.107972_bib11","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41586-024-07929-5","article-title":"A brain-to-gut signal controls intestinal fat absorption","volume":"634","author":"Lyu","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/db16-0533","article-title":"Ire1alpha in pomc neurons is required for thermogenesis and glycemia","volume":"66","author":"Yao","year":"2017","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.phrs.2025.107972_bib13","article-title":"The Sympathetic-Immune milieu in metabolic health and diseases: insights from pancreas, liver, intestine, and adipose tissues","volume":"11","author":"Ren","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cmet.2021.01.012","article-title":"Metabolic stress drives sympathetic neuropathy within the liver","volume":"33","author":"Liu","year":"2021","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249556","article-title":"Intrahepatic distribution of nerve fibers and alterations due to fibrosis in diseased liver","volume":"16","author":"Mizuno","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib16","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00195.2018","article-title":"Vagus nerve cholinergic circuitry to the liver and the gastrointestinal tract in the neuroimmune communicatome","volume":"315","author":"Metz","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib17","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1002\/hep.32055","article-title":"Hepatic nervous system in development, regeneration, and disease","volume":"74","author":"Miller","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0043-57237","article-title":"Hepatic innervations and nonalcoholic fatty liver disease","volume":"43","author":"Adori","year":"2023","journal-title":"Semin Liver Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-024-03181-w","article-title":"Neuroimmune modulation in liver pathophysiology","volume":"21","author":"Zou","year":"2024","journal-title":"J. Neuroinflamm."},{"issue":"30","key":"10.1016\/j.phrs.2025.107972_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg5733","article-title":"Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging","volume":"7","author":"Adori","year":"2021","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib22","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1038\/s41467-019-10684-1","article-title":"Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis","volume":"10","author":"Hackl","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine Organ-Linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051518","article-title":"Interplay of dietary fatty acids and cholesterol impacts brain mitochondria and insulin action","volume":"12","author":"Schell","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2025.107972_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-024-08108-2","article-title":"Leptin-activated hypothalamic BNC2 neurons acutely suppress food intake","author":"Tan","year":"2024","journal-title":"Nature"},{"issue":"6707","key":"10.1016\/j.phrs.2025.107972_bib26","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.adj2537","article-title":"GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans","volume":"385","author":"Kim","year":"2024","journal-title":"Science"},{"issue":"6665","key":"10.1016\/j.phrs.2025.107972_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl7398","article-title":"Integrative neurocircuits that control metabolism and food intake","volume":"381","author":"Bruning","year":"2023","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cmet.2024.02.010","article-title":"Age-related ciliopathy: obesogenic shortening of melanocortin-4 receptor-bearing neuronal primary cilia","volume":"36","author":"Oya","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2025.107972_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-024-08098-1","article-title":"A subcortical feeding circuit linking an interoceptive node to jaw movement","author":"Kosse","year":"2024","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.phrs.2025.107972_bib30","first-page":"1117","article-title":"Intracerebroventricular injection of ghrelin receptor antagonist alleviated NAFLD via improving hypothalamic insulin resistance","volume":"25","author":"Gong","year":"2022","journal-title":"Iran. J. Basic Med Sci."},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.7150\/thno.89602","article-title":"Palmitoylation of PKCdelta by ZDHHC5 in hypothalamic microglia presents as a therapeutic target for fatty liver disease,","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s13679-024-00556-1","article-title":"Role of glucocorticoids in metabolic Dysfunction-Associated steatotic liver disease","volume":"13","author":"Polyzos","year":"2024","journal-title":"Curr. Obes. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2012.10.051","article-title":"Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic\/JNK1 pathways","volume":"144","author":"Imbernon","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"Muller","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s42255-022-00587-9","article-title":"Food-seeking behavior is triggered by skin ultraviolet exposure in males","volume":"4","author":"Parikh","year":"2022","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib36","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41467-020-15328-3","article-title":"Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease","volume":"11","author":"Jiang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107972_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1213372","article-title":"Hunger & satiety signals: another key mechanism involved in the NAFLD pathway","volume":"14","author":"Lopez-Mendez","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib38","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000518969","article-title":"Hypothalamic overexpression of neurosecretory protein GL leads to obesity in Male C57BL\/6J mice","volume":"112","author":"Narimatsu","year":"2022","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.neuron.2013.02.018","article-title":"Hypothalamic survival circuits: blueprints for purposive behaviors","volume":"77","author":"Sternson","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107972_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2021.12.128","article-title":"Association between nonalcoholic fatty liver disease and depression: a systematic review and meta-analysis of observational studies","volume":"301","author":"Gu","year":"2022","journal-title":"J. Affect Disord."},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/hepr.12760","article-title":"Autonomic nervous system and the liver","volume":"47","author":"Mizuno","year":"2017","journal-title":"Hepatol. Res"},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4254\/wjh.v6.i3.137","article-title":"And I. Rogoveanu, role of intrahepatic innervation in regulating the activity of liver cells","volume":"6","author":"Streba","year":"2014","journal-title":"World J. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/j.2040-4603.2013.tb00506.x","article-title":"Hepatic nervous system and neurobiology of the liver","volume":"3","author":"Jensen","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.phrs.2025.107972_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fmed.2020.00062","article-title":"Hepatic autonomic nervous system and neurotrophic factors regulate the pathogenesis and progression of Non-alcoholic fatty liver disease","volume":"7","author":"Amir","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.phrs.2025.107972_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainresbull.2022.04.015","article-title":"The central nervous system control of energy homeostasis: high fat diet induced hypothalamic microinflammation and obesity","volume":"185","author":"Yan","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(20)30113-3","article-title":"Central nervous pathways of insulin action in the control of metabolism and food intake","volume":"8","author":"Kullmann","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib47","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s42255-021-00408-5","article-title":"Central nervous system regulation of organismal energy and glucose homeostasis","volume":"3","author":"Myers","year":"2021","journal-title":"Nat. Metab."},{"issue":"5775","key":"10.1016\/j.phrs.2025.107972_bib48","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1126\/science.1124147","article-title":"Hypothalamic mTOR signaling regulates food intake","volume":"312","author":"Cota","year":"2006","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.phrs.2025.107972_bib49","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/obr.12308","article-title":"Non-alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization","volume":"16","author":"Sabath","year":"2015","journal-title":"Obes. Rev."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib50","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pharmthera.2010.02.002","article-title":"Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications,","volume":"126","author":"Lambert","year":"2010","journal-title":"Pharm. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib52","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1210\/jc.2009-2801","article-title":"Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities","volume":"95","author":"Licht","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2025.107972_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.752944","article-title":"Autonomic imbalance increases the risk for Non-alcoholic fatty liver disease","volume":"12","author":"Jung","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"17","key":"10.1016\/j.phrs.2025.107972_bib54","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1113\/JP277994","article-title":"Liver sympathetic denervation reverses obesity-induced hepatic steatosis","volume":"597","author":"Hurr","year":"2019","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clinre.2011.09.012","article-title":"Liver denervation increases the levels of serum triglyceride and cholesterol via increases in the rate of VLDL secretion","volume":"36","author":"Rasouli","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cmet.2013.07.001","article-title":"Chronic sympathoexcitation through loss of Vav3, a Rac1 activator, results in divergent effects on metabolic syndrome and obesity depending on diet","volume":"18","author":"Menacho-Marquez","year":"2013","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib57","article-title":"RIIbeta-PKA in GABAergic neurons of dorsal median hypothalamus governs White adipose browning","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"17","key":"10.1016\/j.phrs.2025.107972_bib58","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1219542110","article-title":"Deficiency of the RIIbeta subunit of PKA affects locomotor activity and energy homeostasis in distinct neuronal populations,","volume":"110","author":"Zheng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005963","article-title":"Disruption of protein kinase a in mice enhances healthy aging","volume":"4","author":"Enns","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1073\/pnas.0710607105","article-title":"Disruption of the RIIbeta subunit of PKA reverses the obesity syndrome of agouti lethal yellow mice","volume":"105","author":"Czyzyk","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107972_bib61","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1038\/ncomms9237","article-title":"Hypothalamic PKA regulates leptin sensitivity and adiposity","volume":"6","author":"Yang","year":"2015","journal-title":"Nat. Commun."},{"issue":"6069","key":"10.1016\/j.phrs.2025.107972_bib62","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.1213979","article-title":"Structure and allostery of the PKA RIIbeta tetrameric holoenzyme","volume":"335","author":"Zhang","year":"2012","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.phrs.2025.107972_bib63","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.immuni.2022.06.018","article-title":"Microglia-derived PDGFB promotes neuronal potassium currents to suppress basal sympathetic tonicity and limit hypertension","volume":"55","author":"Bi","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib64","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1038\/s41467-024-52815-3","article-title":"Hypothalamus-sympathetic-liver axis mediates the early phase of stress-induced hyperglycemia in the Male mice","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib65","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114465","article-title":"Excessive free fatty acid sensing in pituitary lactotrophs elicits steatotic liver disease by decreasing prolactin levels","volume":"43","author":"Ji","year":"2024","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.phrs.2025.107972_bib67","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1172\/JCI91578","article-title":"The long road to leptin","volume":"126","author":"Friedman","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.phrs.2025.107972_bib68","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2174\/138161210791208884","article-title":"Leptin: the prototypic adipocytokine and its role in NAFLD","volume":"16","author":"Procaccini","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib69","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jhep.2023.06.019","article-title":"Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2","volume":"79","author":"Li","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00125-015-3769-3","article-title":"Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"59","author":"Polyzos","year":"2016","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib71","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000348541","article-title":"Rapid improvement of hepatic steatosis after initiation of leptin substitution in a leptin-deficient girl","volume":"79","author":"von Schnurbein","year":"2013","journal-title":"Horm. Res. Paediatr."},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11684-013-0263-5","article-title":"Leptin signaling and leptin resistance","volume":"7","author":"Zhou","year":"2013","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1432-1033.2004.04391.x","article-title":"Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines","volume":"272","author":"Hekerman","year":"2005","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib74","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1210\/me.2007-0389","article-title":"Specific physiological roles for signal transducer and activator of transcription 3 in leptin receptor-expressing neurons","volume":"22","author":"Piper","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib75","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2337\/db08-0822","article-title":"Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin","volume":"58","author":"Rahmouni","year":"2009","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.phrs.2025.107972_bib76","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/MCB.06712-11","article-title":"Shp2 controls female body weight and energy balance by integrating leptin and estrogen signals","volume":"32","author":"He","year":"2012","journal-title":"Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107972_bib77","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm.2026","article-title":"The obesity susceptibility gene cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake","volume":"15","author":"Plum","year":"2009","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib78","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nm1392","article-title":"Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake","volume":"12","author":"Kitamura","year":"2006","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib79","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1074\/jbc.M804965200","article-title":"FoxO1 inhibits leptin regulation of pro-opiomelanocortin promoter activity by blocking STAT3 interaction with specificity protein 1","volume":"284","author":"Yang","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib80","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cmet.2023.02.004","article-title":"Estradiol regulates leptin sensitivity to control feeding via hypothalamic Cited1","volume":"35","author":"Gonzalez-Garcia","year":"2023","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib81","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1172\/JCI27123","article-title":"Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity","volume":"116","author":"Plum","year":"2006","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib82","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1210\/en.2002-0115","article-title":"Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of koletsky (fa(k)\/fa(k)) rats","volume":"144","author":"Morton","year":"2003","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib83","doi-asserted-by":"crossref","first-page":"E1247","DOI":"10.1152\/ajpendo.00274.2009","article-title":"Recent advances in understanding leptin signaling and leptin resistance","volume":"297","author":"Morris","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cmet.2008.12.001","article-title":"The geometry of leptin action in the brain: more complicated than a simple ARC","volume":"9","author":"Myers","year":"2009","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.phrs.2025.107972_bib85","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00592-023-02109-9","article-title":"Glucagon-like peptide-1 analog therapy in rare genetic diseases: monogenic obesity, monogenic diabetes, and spinal muscular atrophy","volume":"60","author":"Zaitoon","year":"2023","journal-title":"Acta Diabetol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib86","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1210\/en.2010-1135","article-title":"Jr., neuropeptide y and agouti-related peptide mediate complementary functions of hyperphagia and reduced energy expenditure in leptin receptor deficiency","volume":"152","author":"Luo","year":"2011","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.phrs.2025.107972_bib87","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/nn1548","article-title":"Agouti-related peptide-expressing neurons are mandatory for feeding","volume":"8","author":"Gropp","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2025.107972_bib88","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1096\/fj.04-3434fje","article-title":"Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype,","volume":"19","author":"Bewick","year":"2005","journal-title":"FASEB J."},{"issue":"17","key":"10.1016\/j.phrs.2025.107972_bib89","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1016\/j.cub.2021.06.048","article-title":"Hypothalamic control of interoceptive hunger","volume":"31","author":"Siemian","year":"2021","journal-title":"Curr. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib90","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1172\/JCI45888","article-title":"Sixteen years and counting: an update on leptin in energy balance","volume":"121","author":"Gautron","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib91","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1210\/er.2006-0034","article-title":"Studies on the physiological functions of the melanocortin system","volume":"27","author":"Cone","year":"2006","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib92","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156722","article-title":"LepRb+ cell-specific deletion of slug mitigates obesity and nonalcoholic fatty liver disease in mice,","volume":"133","author":"Kim","year":"2023","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib93","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/en.2006-1119","article-title":"Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding","volume":"148","author":"Xu","year":"2007","journal-title":"Endocrinology"},{"issue":"42","key":"10.1016\/j.phrs.2025.107972_bib94","doi-asserted-by":"crossref","first-page":"31019","DOI":"10.1074\/jbc.M702838200","article-title":"Jr., the long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms","volume":"282","author":"Gong","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib95","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neulet.2007.02.074","article-title":"Nuclear translocation of the transcription factor STAT5 in the rat brain after systemic leptin administration","volume":"417","author":"Mutze","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"47","key":"10.1016\/j.phrs.2025.107972_bib96","doi-asserted-by":"crossref","first-page":"18619","DOI":"10.1073\/pnas.0804589105","article-title":"Tyrosine-dependent and -independent actions of leptin receptor in control of energy balance and glucose homeostasis","volume":"105","author":"Jiang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib97","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI24301","article-title":"PI3K integrates the action of insulin and leptin on hypothalamic neurons","volume":"115","author":"Xu","year":"2005","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib98","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cmet.2008.10.004","article-title":"Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis","volume":"8","author":"Blouet","year":"2008","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib99","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cmet.2011.09.011","article-title":"Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance","volume":"14","author":"Loh","year":"2011","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib100","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.cmet.2024.04.014","article-title":"Obesity disrupts the pituitary-hepatic UPR communication leading to NAFLD progression","volume":"36","author":"Qian","year":"2024","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.phrs.2025.107972_bib101","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1016\/j.celrep.2020.02.063","article-title":"OXR1A, a coactivator of PRMT5 regulating histone arginine methylation","volume":"30","author":"Yang","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/en.2010-0537","article-title":"GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism","volume":"152","author":"Barclay","year":"2011","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib103","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1210\/clinem\/dgac088","article-title":"Growth hormone and Insulin-Like growth factor 1 regulation of nonalcoholic fatty liver disease","volume":"107","author":"Dichtel","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2025.107972_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.111075","article-title":"GHR signalling: receptor activation and degradation mechanisms","volume":"520","author":"Chhabra","year":"2021","journal-title":"Mol. Cell Endocrinol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib105","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2006.12.024","article-title":"Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency","volume":"132","author":"Takahashi","year":"2007","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.phrs.2025.107972_bib106","doi-asserted-by":"crossref","first-page":"E1640","DOI":"10.1210\/jc.2011-1227","article-title":"Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I","volume":"96","author":"Arturi","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib107","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/hepr.12408","article-title":"Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease","volume":"45","author":"Sumida","year":"2015","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib108","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-12-0252","article-title":"Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy","volume":"167","author":"Nishizawa","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib109","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ghir.2014.07.002","article-title":"Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency","volume":"24","author":"Matsumoto","year":"2014","journal-title":"Growth Horm. IGF Res."},{"issue":"17","key":"10.1016\/j.phrs.2025.107972_bib110","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.7150\/thno.61192","article-title":"Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib111","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/me.2009-0233","article-title":"In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2","volume":"24","author":"Barclay","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib112","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1172\/JCI42894","article-title":"Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2","volume":"121","author":"Sos","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/HEP.0000000000000307","article-title":"p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1\/FOXO1\/IGF-1 signaling","volume":"78","author":"Kundu","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib114","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2012.05.115","article-title":"GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model","volume":"423","author":"Nishizawa","year":"2012","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.phrs.2025.107972_bib115","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1530\/EC-18-0499","article-title":"Reduced expression of thyroid hormone receptor beta in human nonalcoholic steatohepatitis","volume":"7","author":"Krause","year":"2018","journal-title":"Endocr. Connect"},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib116","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1177\/0300060519851624","article-title":"Effects of thyroid hormone and depression on common components of central obesity","volume":"47","author":"Du","year":"2019","journal-title":"J. Int Med Res"},{"issue":"9","key":"10.1016\/j.phrs.2025.107972_bib117","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/thy.2018.0664","article-title":"Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists","volume":"29","author":"Sinha","year":"2019","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib118","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ueg2.12124","article-title":"Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany","volume":"9","author":"Labenz","year":"2021","journal-title":"U. Eur. Gastroenterol. J."},{"issue":"11","key":"10.1016\/j.phrs.2025.107972_bib119","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.dld.2018.08.012","article-title":"Association of non-alcoholic fatty liver disease with thyroid function: a systematic review and meta-analysis","volume":"50","author":"Guo","year":"2018","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12876-021-02011-0","article-title":"Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight\/obese Chinese adults","volume":"21","author":"Ma","year":"2021","journal-title":"BMC Gastroenterol."},{"issue":"8","key":"10.1016\/j.phrs.2025.107972_bib121","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s10620-019-05687-3","article-title":"Low free triiodothyronine is associated with advanced fibrosis in patients at high risk for nonalcoholic steatohepatitis","volume":"64","author":"Manka","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"10213","key":"10.1016\/j.phrs.2025.107972_bib122","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030862","article-title":"The influence of reducing diets on changes in thyroid parameters in women suffering from obesity and hashimoto's disease","volume":"13","author":"Ostrowska","year":"2021","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib124","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3350\/cmh.2015.21.4.372","article-title":"Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: a 4-year retrospective cohort study","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Mol. Hepatol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000492324","article-title":"Association between Thyroid-Stimulating hormone levels and Non-Alcoholic fatty liver disease is not independent from metabolic syndrome criteria","volume":"7","author":"Janovsky","year":"2018","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.phrs.2025.107972_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155713","article-title":"Glucocorticoids and intrauterine programming of nonalcoholic fatty liver disease","volume":"150","author":"Chen","year":"2024","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.phrs.2025.107972_bib127","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/jc.2016-2498","article-title":"Genetic variation in the 11beta-hydroxysteroid-dehydrogenase 1 gene determines NAFLD and visceral obesity,","volume":"101","author":"Lutz","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib128","first-page":"479","article-title":"And E.M.-S. Group, influence of plasma cortisol and other laboratory parameters on nonalcoholic fatty liver disease","volume":"47","author":"Hubel","year":"2015","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/a-2043-1044","article-title":"Prolactin is a key factor for nonalcoholic fatty liver disease in obese children","volume":"55","author":"Zhang","year":"2023","journal-title":"Horm. Metab. Res."},{"issue":"10","key":"10.1016\/j.phrs.2025.107972_bib130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062252","article-title":"Cross-sectional association between prolactin levels and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a retrospective analysis of patients from a single hospital in China","volume":"12","author":"Zhang","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.phrs.2025.107972_bib131","first-page":"56","article-title":"Prolactin promotes adipose tissue fitness and insulin sensitivity in obese males","volume":"158","author":"Ruiz-Herrera","year":"2017","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib132","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bbrc.2018.03.048","article-title":"Ablation of prolactin receptor increases hepatic triglyceride accumulation","volume":"498","author":"Shao","year":"2018","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib133","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2018.01.035","article-title":"Prolactin improves hepatic steatosis via CD36 pathway","volume":"68","author":"Zhang","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2025.107972_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1001703","article-title":"The beneficial metabolic actions of prolactin","volume":"13","author":"Macotela","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"10","key":"10.1016\/j.phrs.2025.107972_bib135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.4103\/0366-6999.181967","article-title":"Evaluation of basal serum adrenocorticotropic hormone and cortisol levels and their relationship with nonalcoholic fatty liver disease in Male patients with idiopathic hypogonadotropic hypogonadism","volume":"129","author":"Wang","year":"2016","journal-title":"Chin. Med. J. (Engl. )"},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib136","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2025.107972_bib137","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.steroids.2018.04.004","article-title":"Possible mechanisms underlying fatty liver in a rat model of Male hypogonadism: a protective role for testosterone","volume":"135","author":"Sakr","year":"2018","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.phrs.2025.107972_bib138","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/liv.15786","article-title":"Endogenous sex hormones and nonalcoholic fatty liver disease in US adults","volume":"44","author":"Kim","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.phrs.2025.107972_bib139","article-title":"Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharm."},{"issue":"10","key":"10.1016\/j.phrs.2025.107972_bib140","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.cmet.2024.09.003","article-title":"GLP-1 programs the neurovascular landscape","volume":"36","author":"Chen","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2025.107972_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1046130","article-title":"Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model","volume":"13","author":"Niu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib142","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","article-title":"Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor","volume":"36","author":"Regmi","year":"2024","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.phrs.2025.107972_bib143","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"And S.-N. Investigators, tirzepatide for metabolic Dysfunction-Associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2025.107972_bib144","article-title":"Advancements in pharmacological treatment of NAFLD\/MASLD: a focus on metabolic and liver-targeted interventions","volume":"12","author":"Ciardullo","year":"2024","journal-title":"Gastroenterol. Rep. (Oxf. )"},{"key":"10.1016\/j.phrs.2025.107972_bib145","article-title":"Liraglutide alleviates hepatic steatosis and liver injury in T2MD rats via a GLP-1R dependent AMPK pathway","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2025.107972_bib146","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2022.06.002","article-title":"Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions","volume":"34","author":"Imbernon","year":"2022","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib147","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s11095-022-03302-1","article-title":"Therapeutic potential of semaglutide, a newer GLP-1 receptor agonist, in abating obesity, Non-Alcoholic steatohepatitis and neurodegenerative diseases: a narrative review","volume":"39","author":"Mahapatra","year":"2022","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib148","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40272-022-00532-z","article-title":"Phentermine\/Topiramate: pediatric first approval","volume":"24","author":"Dhillon","year":"2022","journal-title":"Paediatr. Drugs"},{"issue":"3","key":"10.1016\/j.phrs.2025.107972_bib149","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000524805","article-title":"Effect of phentermine on hepatic steatosis in bariatric surgery: a pilot study","volume":"31","author":"Perez-Cruz","year":"2022","journal-title":"Med Princ. Pr."},{"issue":"6","key":"10.1016\/j.phrs.2025.107972_bib150","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2337\/dc19-1892","article-title":"Effects of novel dual GIP and GLP-1 receptor agonist tirzepatide on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes","volume":"43","author":"Hartman","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib151","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000540534","article-title":"Effect of dual Glucagon-Like peptide 1\/Glucose-Dependent insulinotropic polypeptide receptor agonist (Tirzepatide) versus bariatric surgery on weight loss and nonalcoholic fatty liver disease","volume":"33","author":"Al-Sabah","year":"2024","journal-title":"Med Princ. Pr."},{"issue":"5","key":"10.1016\/j.phrs.2025.107972_bib152","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.tem.2023.02.005","article-title":"Neuroendocrine regulation in stroke","volume":"34","author":"Datta","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"issue":"772","key":"10.1016\/j.phrs.2025.107972_bib153","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh9940","article-title":"Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population","volume":"16","author":"Ding","year":"2024","journal-title":"Sci. Transl. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:29:48Z","timestamp":1773131388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825003974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":153,"alternative-id":["S1043661825003974"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107972","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hypothalamus in the pathophysiological process of MASLD and advances in drug discovery","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107972"}}